Cite
HARVARD Citation
Kim, R. et al. (2020). A multi‐institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer. Cancer. 126 (15), pp. 3464-3470. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kim, R. et al. (2020). A multi‐institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer. Cancer. 126 (15), pp. 3464-3470. [Online].